First Human Trials for Recombinant Dengue Fever Vaccine
Phase one clinical trials to start for Dengue Fever Vaccine program
26-Aug-2009 -
Acuvax Limited announces that the dengue fever vaccine is set to begin Phase 1 safety trials in the USA through its affiliate company Hawaii Biotech Inc. Hawaii Biotech Inc, has initiated this phase one clinical study with their monovalent dengue vaccine candidate. The double-blind, placebo ...
antibodies
clinical trials
dengue fever